Pfizer Stock - $MYOV Myovant Sciences and Pfizer Announce Positive One-Year Data from Phase 3 SPIRIT Extension Study of Once-Daily Relugolix Combination Therapy in Women with Endometriosis https://t.co/Oy9myE59uh

3:55am PST - January 26th, 2021

$MYOV Myovant Sciences and Pfizer Announce Positive One-Year Data from Phase 3 SPIRIT Extension Study of Once-Daily Relugolix Combination Therapy in Women with Endometriosis https://t.co/Oy9myE59uh

0 retweets 1 likes -